These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.
    Author: Zeng C, Wu T, Zhen Y, Xia XP, Zhao Y.
    Journal: Cell Mol Immunol; 2005 Dec; 2(6):427-32. PubMed ID: 16426492.
    Abstract:
    B and T lymphocyte attenuator (BTLA), identified as an immune inhibitory receptor recently, plays widespread roles on T and B cells. Emerging evidence has generated plentiful information on the mechanisms which BTLA mediates negative regulation in immune responses and involves in a variety of physiological and pathological processes. The exploration of the biological mechanisms and regulation of BTLA will open possibilities on novel therapeutic strategies in immune-related diseases.
    [Abstract] [Full Text] [Related] [New Search]